Immunotherapy Today

Immunotherapy News From Around The World

< Immunotherapy Today home

Author: btwatson

  • Piotrowska Addresses Immunotherapy Treatment in NSCLC With Mutations – Targeted Oncology
    Piotrowska Addresses Immunotherapy Treatment in NSCLC With Mutations – Targeted Oncology
  • Kris Details Use of Immunotherapies After Lung Cancer Progression – Targeted Oncology
    Kris Details Use of Immunotherapies After Lung Cancer Progression – Targeted Oncology
  • New approach can make immunotherapy effective against cancers – News-Medical.Net
    New approach can make immunotherapy effective against cancers – News-Medical.Net
  • Study: BIRC2 overexpression could be a key marker for immunotherapy resistance – News-Medical.Net
    Study: BIRC2 overexpression could be a key marker for immunotherapy resistance – News-Medical.Net
  • ICR welcomes approval of immunotherapy for head and neck cancer in Scotland but warns of ‘home nations lottery’ – The Institute of Cancer Research
    ICR welcomes approval of immunotherapy for head and neck cancer in Scotland but warns of ‘home nations lottery’ – The Institute of Cancer Research
  • AbbVie has 47 reasons for its $2B cancer immunotherapy partnership with I-Mab – MedCity News
    AbbVie has 47 reasons for its $2B cancer immunotherapy partnership with I-Mab – MedCity News
  • Effective cancer immunotherapy further linked to regulating a cell ‘suicide’ gene – Science Daily
  • Why Young and Female Patients Don’t Respond as Well to Cancer Immunotherapy – UC San Diego Health
    Why Young and Female Patients Don’t Respond as Well to Cancer Immunotherapy – UC San Diego Health
  • New tool predicts patients’ immunotherapy response – SelectScience
    New tool predicts patients’ immunotherapy response – SelectScience
  • Celyad Oncology’s High Hopes for a Path Forward in Cancer Immunotherapy with CYAD-211 – BioSpace
    Celyad Oncology’s High Hopes for a Path Forward in Cancer Immunotherapy with CYAD-211 – BioSpace
< Newer Entries   |   Older Entries >
Copyright 2018 ImmunoTherapyToday.com